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Key points
• Continuing smokers with 
depression are more likely 
to be nicotine dependent, to 
smoke more heavily and to 
have problems stopping 
smoking.
• It is important to understand 
the specific relation 
between depression and 
smoking in individual 
patients.
• Addressing both smoking 
cessation and depression 
has multiple benefits for 
mental and physical health.
• Useful strategies to help 
patients quit include 
motivational interviewing 
and development of a 
smoking cessation plan in 
collaboration with patients. 
• A collaborative multifaceted 
approach is often required, 
with referral to Quitline, to a 
tobacco treatment specialist 
and/or for psychological 
support.
• A range of online resources 
and telephone services 
are available for use by 
clinicians to complement 
treatment.
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Helping smokers with current or past depression quit smoking can be 
challenging. A range of online resources and telephone services are 
available for clinicians to complement smoking cessation treatment for 
these patients.
S
moking is now seen as a chronic condition 
that requires repeated smoking cessation 
advice, treatment and monitoring.1 Most 
smokers relapse after a quit attempt and 
may try to quit on multiple occasions before 
they succeed.2 Australian guidelines recommend 
that health professionals should take every 
opportunity to identify smokers, to offer them 
smoking cessation treatment in the form of brief 
advice to quit and pharmacotherapy, and to refer 
them to Quitline or other suitable programs.3 
Selected treatment-refractory patients can be 
referred to a tobacco treatment specialist. 
The 2010 National Drug Strategy Household 
Survey reported that 18% of Australians aged 
14 years and over are smokers.4 This low rate 
by international standards follows decades 
of proactive public health policy and the avail-
ability of good smoking cessation treatment 
resources, including Quitline and well-informed 
GPs, pharmacists and other health profes-
sionals. The survey report also notes that 
 ‘Compared with non-smokers (never smoked 
or ex-smokers), smokers were: more likely to 
rate their health as being fair or poor; more 
likely to have asthma; twice as likely to have 
been diagnosed or treated for a mental illness; 
and more likely to report high or very high 
levels of psychological distress in the preceding 
four-week period.’4
However, continuing smokers with depression 
are more likely to be nicotine dependent, to smoke 
more heavily, to have problems stopping smoking 
and to have other medical and mental health 
conditions. Facts about smoking and depression 
are summarised in the box on page 47. 
A recent review concludes that ‘despite the 
availability of effective smoking cessation 
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pharmacotherapies and psychosocial inter-
ventions, as well as increasing evidence that 
 individuals with psychiatric disorders are 
 motivated to quit, nicotine dependence remains 
an under-treated and under-recognised problem 
within this patient population’.12 The authors 
postulate a number of reasons for this,  including 
lack of research into newer approaches and 
higher  tolerance of smoking in people with a 
mental illness. They call for an attitude shift in 
the treating clinicians and an individualised 
approach for these patients. 
GPs have important roles in promoting men-
tal and physical health and proactively identi-
fying and assisting with problems related to 
depression and anxiety, which can be barriers 
to smoking cessation. It is challenging for any 
one clinician to have the expertise and time to 
effectively manage both depression and smoking 
cessation. In this article we focus on services 
and resources available to GPs and other health 
professionals to assist patients with a history of 
depression in smoking cessation. Some examples 
are outlined in the box on page 48. 
APPLYING THE 5AS APPROACH TO 
SMOKERS WITH DEPRESSION
The 5As (ask, assess, advise, assist and arrange 
follow up) are the suggested framework for 
providing smoking cessation support in clinical 
practice.3 Issues of relevance to depression 
under each of the 5As are as follows.
Ask. Enquire about smoking in all patients 
with depression. Smoking rates are high and 
relapse is common in people with depression 
so it is important to keep asking. 
Assess. Assess the stage of change in relation 
to smoking and the relation between smoking 
and depression for the individual. Smoking is 
commonly triggered by low mood, lack of 
meaningful activity, low self-esteem and use 
of alcohol and recreational substances. People 
with depression (and other dependence behav-
iours, including gambling) are more likely to 
be nicotine dependent. Explore which came 
first, smoking or depression, and use of other 
substances such as sedatives and stimulants.
Advise. Smokers with depression should 
be informed in a way that is clear but non- 
confrontational of the importance of quitting 
for their physical and mental health, and the 
increasing evidence that depression actually 
improves after quitting. 
Assist. Motivational interviewing strategies 
such as exploring ambivalence can be used to 
encourage change. A useful motivating tactic 
involves attributing patients’ conditions to 
 smoking – for example, ‘smoker’s heart’ and 
‘smoker’s lung’ – and informing them of their 
‘lung age’ (see the box on page 48 for an online 
‘lung clock’).13 Be willing to provide individually 
 tailored information on the health effects of 
smoking and benefits of quitting. Offer collab-
orative care with Quitline or a tobacco treatment 
specialist and/or referral for psychological 
 support such as cognitive behavioural therapy 
and mood management. For nicotine-dependent 
patients, offer pharmacotherapy based on 
 clinical suitability and patient preference. 
Arrange follow up. Try to maintain contact 
during a quit attempt to review progress and 
problems, encourage continuation of phar-
macotherapy, monitor mood and encourage use 
of support services. Longer courses of  smoking 
cessation pharmacotherapy may be indicated. 
Patients taking antidepressants may need a 
 dosage reduction after ceasing smoking. Inter-
actions between nicotine and psychoactive 
medications are summarised in the box on 
page 49.14,15  Also, encourage patients who have 
FACTS ABOUT TOBACCO SMOKING, QUITTING AND DEPRESSION
• Tobacco smoking in patients with depression is more common than in the general 
population, because of complex neurobiological and psychological mechanisms. 
• Nicotine dependence exposes smokers with co-occurring depression to 
increased risks of smoking-related morbidity and mortality, and to detrimental 
impacts on their quality of life. 
• Some common medical illnesses (e.g. diabetes, chronic obstructive pulmonary 
 disease and vascular disease) are associated with depression and are also 
 common in smokers.
• Current smoking is consistently associated with suicidal ideation and suicide in 
both case-control and cohort studies;5,6 however, smoking cessation has not 
been  associated with suicide in the few studies available.
• In some smokers, stopping smoking may lead to depressive symptoms while 
 quitting but there is some evidence to suggest that cessation does not increase 
the risk of  episodes of major depression.7
• Flexible, individualised smoking cessation programs are the key to success in this 
patient population. 
• Nicotine lowers serum levels of some antidepressants; smoking cessation can 
increase side effects and necessitate dose adjustment.
• GPs working in a collaborative care arrangement with Quitline have been shown 
to make a difference to outcomes for smokers with a history of depression.8 
• Reviews of smoking and depression or mental illness provide more detail and an 
Australian context.9-11
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quit to consider changes needed to their 
life, work patterns and social network to 
maintain their nonsmoking status.
The following three cases illustrate the 
principles of collaborative care in helping 
smokers with a history of depression quit 
smoking.
CASE 1: MARIA 
Maria is 55 years old and works as a 
 laboratory technician. She has been smok-
ing for 30 years (a total of 33 pack years). 
She stopped smoking five years ago by 
going ‘cold turkey’ but resumed (at 25 
 cigarettes per day) after her marriage broke 
down a year ago. She has some insight into 
her problems. She has three children and 
now has a grandson; she wants to stop 
smoking before he is ‘old enough to 
 understand’. She had some depressive 
symptoms and put on 10 kg in weight when 
she stopped previously and does not want 
SmokerS wItH depreSSIon CONTINUED 
SERVICES AND RESOURCES TO HELP WITH A COLLABORATIVE APPROACH TO SMOKING CESSATION
resources for smoking cessation
Gp guidelines. Revised guidelines for smoking cessation 
 published by the Royal Australian College of General Practitioners 
(RACGP) in 2011 describe the latest pharmacotherapy available 
and smoking cessation in populations with special needs.3 
Quitline. The national Quitline service (13 7848) offers smoking 
cessation advice from staff trained in cognitive behavioural treat-
ment of smoking, counselling support and delivery of tailored 
resources designed to support the medical advice given to callers 
by their treating doctors. Completing the referral form (available in 
Medical Director and the GP guidelines on smoking cessation3 
and at www.quitnow.gov.au) activates a call to your patient from 
your state Quitline. Quitline services are increasingly aware of the 
complex interactions between smoking cessation and mental 
health symptoms and medications. In response, some state 
Quitlines (Victoria, SA and NSW) now offer tailored callback counsel-
ling sensitive to the needs of smokers with a history of depression. 
Australian Association of Smoking  Cessation professionals 
(AASCp). This is a nonprofit association of health  professionals with 
special expertise in smoking. Members are accredited by the associ-
ation and have access to a wide range of resources and support. 
GPs can join to upgrade their skills or search the website for a 
 tobacco treatment specialist in their area (www.aascp.org.au).
resources specific to smokers with mental illnesses
Fact sheets. The NSW Ministry of Health website has a series of 
worksheets to  facilitate smoking cessation in people with mental 
illness (e.g. www0.health.nsw.gov.au/PublicHealth/healthpromotion/
tobacco/mh/tools.asp and www0.health.nsw.gov.au/pubs/2012/
pdf/tool_11_quick_guide_to_mo.pdf). These include a summary of 
the impact of smoking on commonly used psychotropic medications 
(www0.health.nsw.gov.au/pubs/2012/pdf/tool_14_medication_
intera.pdf). 
SmArt recovery. This voluntary self-help group assists people 
recovering from alcohol, drug use and other addictive behaviours. 
SMART Recovery teaches practical skills to help people deal with 
problems enabling them to abstain and achieve a healthy lifestyle-
balance. The SMART Recovery program has four  key points: 
building and maintaining motivation, coping with urges, problem 
solving, and lifestyle balance (http://smartrecoveryaustralia.com.au).
resources about depression
Fact sheets. Online fact sheets for patients on depression-related 
subjects are available from: 
• the Black Dog Institute (www.blackdoginstitute.org.au), 
including fact sheets on techniques such as mindfulness in 
everyday life, structured problem solving and honest 
communication. The site also includes other practical 
resources for use by GPs to help them in management of 
mood disorders (www.blackdoginstitute.org.au/
healthprofessionals/resources/thepsychologicaltoolkit.cfm).
• beyondblue (www.beyondblue.org.au), including a 




this way Up. This website offers an online cognitive behavioural 
therapy program to treat anxiety and depression (http://thiswayup.
org.au/clinic). 
resources for a healthy lifestyle
SnAp guide. The RACGP SNAP guide (S, quit Smoking; N, 
 better Nutrition; A, moderate Alcohol; P, more Physical activity) 
aims to help GPs tackle important behavioural risk factors that 
affect the health of the Australian community. It advises on 
 systematically targeting patients and offering treatment 
 appropriate to their needs (www.racgp.org.au/your-practice/
guidelines/snap).
ABC Health and wellbeing website. This website has authoritative 
and easily accessible information on a wide variety of topics 
(www.abc.net.au/health).
Get Healthy Information and Coaching Service. This is a free, 
confidential telephone service that aims to motivate and help 
 people make lifestyle changes in relation to healthy eating, being 
physically active and achieving/maintaining a healthy weight 
 (telephone 1300 806 258, 8 a.m. to 8 p.m. weekdays; or 
www.gethealthynsw.com.au). 
Lungclock. This free app and website enables GPs to estimate a 
patient’s lung age for use in motivational interviewing 
(www.lungclock.com).
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to go through a similar experience this 
time.
Management and outcome
• Maria’s GP weighs her, measures her 
blood pressure and administers the 
K10 psychological distress measure, 
which includes items related to anxi-
ety and depression.16 The GP tells her 
she scores in the ‘mild’ distress range 
and that the score will provide a good 
baseline. They then discuss her smok-
ing history, including pack years and 
‘lung age’ (see the box on page 48).
• The GP asks Maria ‘How do you feel 
about your smoking?’, consistent 
with the GP guidelines,3 and identi-
fies her stage of change as ‘contem-
plation’. By her next visit, Maria has 
moved to the action phase. 
• Together Maria and her GP create a 
smoking cessation plan (see the box 
on page 50). They set targets for posi-
tive activities (exercise, strategies for 
difficult times of day) before the quit 
date, based on what worked for 
Maria and what she learnt from her 
previous quit attempt. 
• The GP discusses Maria’s concerns 
about her weight and suggests she 
start a weight management 
 program before the quit date. The 
GP tells Maria about some online 




PDFs/quitsmoking.pdf) and refers 
her to a dietitian.
• The GP encourages Maria to track 
her mood on a daily chart (e.g. a 




along with her planned daily exercise 
and positive activities. 
• The GP discusses pharmacotherapy 
options based on clinical  suitability 
and Maria’s preference (pharmaco-
therapy options are listed in Table 1). 
They choose varenicline, and the 
GP explains the dosage titration, 
the possibility of nausea and how to 
minimise this and the need for 
monitoring and follow up for mood 
or behaviour changes.3 Maria is 
enrolled in the ‘My time to quit’ 
program from the manufacturer of 
varenicline, and the GP encourages 
her to make use of this program.
• Maria quits successfully but three 
months later presents with a relapse.
She is in conflict with her ex-husband 
about weekend access to their 
 children and also has some work 
problems. She says ‘I’m stressed, I 
can’t sleep and I’m starting to feel 
depressed. I have had a few 
 cigarettes and they seem to help’. 
• The GP reinforces that people often 
have setbacks and asks Maria what 
she has learned from this quit 
attempt that she could use again. 
The GP also explains that although 
cigarettes may relieve stress in the 
short term, in the long term they 
make stress and mood disorders 
worse.
• The GP prescribes a further 12-week 
course of varenicline after explaining 
that this helps reduce the risk of 
relapse.19 
• The GP arranges for Maria to see the 
mental health nurse in the practice for 
sessions on problem solving and 
assertion skills to apply to her current 
situation. The nurse also encourages 
the use of ‘mindfulness’, a technique 
that promotes living in the moment 
and helps with smoking  cessation as 
well as worry and stress manage-
ment.20 She suggests Maria read some 
online factsheets (see the box on page 
48). Maria finds the mindfulness 
exercises helpful and, after applying 
problem solving techniques, asks a 
friend to go for a walk with her each 
morning to give her extra support. 
• The GP suggests that Maria list ways 
that quitting was helping her fitness 
and also that she take regular daily 
exercise and 10-minute ‘exercise 
bursts’ when she feels anxious or 
wants a cigarette.17 
• The GP discusses with the  practice 
mental health nurse the  possibility 
of referring Maria for counselling 
about her relationship problems 
and to prevent depression relapses 
in the future. The GP also considers 
referring Maria to This Way Up, an 
online cognitive behavioural therapy 
program for depression and to a 
tobacco  treatment specialist if 
necessary.
CASE 2: JACOB 
Jacob is a 58-year-old man who is married 
with two adult children and works as a 
clerk. He has been smoking 20 to 30 
 cigarettes a day for 40 years. He is obese, 
has type 2 diabetes and hypertension, and 
was diagnosed with ischaemic heart 
 disease about three years ago; he is taking 
standard medication for these problems. 
INTERACTIONS BETWEEN 
NICOTINE, ANTIDEPRESSANTS 
AND OTHER PSYCHOACTIVE 
SUBSTRATES14,15
• Cigarette smoking induces activity of 
cytochrome P450 enzymes CYP1A2 
and CYP2B6. This induction is 
 mediated by chemicals in cigarette 
smoke, not nicotine. Enzyme activity is 
thus unaffected by nicotine replacement 
therapy
• Induction of CYP1A2 enzyme activity 
is reversed after one week of stopping 
smoking
• CYP1A2 enzyme induction affects 
amitriptyline,* caffeine, clozapine,* 
duloxetine,* fluvoxamine,* haloperidol, 
imipramine and olanzapine*
• CYP2B6 enzyme induction affects 
methadone
* These medications are most affected by smoking 
cessation and close monitoring is required because 
of the greater likelihood of side effects necessitating 
dose adjustment. For other tricyclic antidepressants, 
serum levels fall but free drug levels rise, minimising 
the overall effect.
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He has had three episodes of depression 
in the past five years and is taking 
 sertraline 100  mg daily, with some 
improvement. His GP has advised him to 
stop smoking. He says ‘I know that I have 
to, but I enjoy smoking.’ He has tried to 
quit ‘a couple of times’ in the past few years, 
but only lasted 24 to 36 hours. It was 
 ‘horrible’, he says. 
Management and outcome 
• The GP assesses Jacob as being at the 
precontemplation stage of quitting.
• The GP makes a quick assessment of 
Jacob’s level of nicotine dependence 
with the following questions, as 
 recommended by the GP guidelines, 
and assesses him as nicotine 
dependent.3
– How soon after waking do you 
have your first cigarette?
– How many cigarettes do you 
smoke each day?
– Have you had cravings for a 
 cigarette or urges to smoke and 
withdrawal symptoms when you 
have tried to quit?
• The GP discusses cardiovascular risk 
factors and demonstrates the effect 
of smoking on Jacob’s score for 
 cardiovascular disease risk using a 
risk calculator (http://www.cvd-
check.org.au).
• The GP explains nicotine replace-
ment therapy (NRT) and reassures 
Jacob about its safety in stable heart 
disease.21 The GP also recommends 
varenicline, as a recent meta-analysis 
showed no significant change in 
rates of cardiac events.22
• Jacob agrees to see the practice nurse 
and the GP to develop a chronic dis-
ease management plan.
• The GP suggests Jacob telephone the 
NSW Health Get Healthy Informa-
tion and Coaching Service to help 
him structure a fitness program and 
NSW Quitline to see how they can 
assist (see the box on page 48). 
• The GP talks about using exercise 
bursts to control cravings and help 
with depression.17 The GP encour-
ages Jacob to exercise daily, for 
example by walking with a ‘buddy’ 
in his lunch breaks at work. 
• Jacob starts walking at lunchtime 
and finds this enjoyable. After 
 several more prompts from the GP, 
Jacob decides to quit smoking. 
• In the lead-up to his quit attempt, the 
GP suggests Jacob:
– get in touch again with Quitline
– smoke a different (less preferred) 
brand of cigarettes for a week, and 
then smoke using his less pre-
ferred hand for another week
– use precessation NRT (patch) for 
two weeks, followed by combina-
tion NRT (patch and 4 mg gum) 
from quit day.
• After two weeks, Jacob feels he has 
more control of his smoking and is 
ready to stop. 
• Jacob visits his GP weekly to allow 
close mood monitoring and also has 
follow-up calls from Quitline. With 
this support, he finds quitting easier 
than he expected.
• The GP continues regular monitor-
ing of Jacob’s mood, weight and 
HbA1c.
SmokerS wItH depreSSIon CONTINUED 
STEPS IN CREATING MARIA’S SMOKING CESSATION PLAN
Step 1. Identify reasons for smoking 
why do I smoke? 
• I smoke when stressed, feeling powerless, angry
what are common triggers? 
• Often around problems with ex-husband, other arguments
what are major roadblocks?
• Not standing up to ex-husband or boss
Step 2. Clarify role of mental health problem 
what part does depression play?
• Depression makes me feel blue and more ‘needy’ for the 
first week 
Step 3. Identify rewards and strengths
• Saving $50 a week means I can go to movies once a week 
with friends – put the money aside each day
• Find some affirmations to use – make into cards
Step 4. establish a quit date
• Wait two weeks until more organised and have walking 
 program in place and medications on hand
• This allows me time to get daily chart underway
Step 5. Identify cessation method and coping strategies
• Contact Quitline and make a plan 
• Start varenicline and nicotine replacement therapy as 
 discussed with GP
• Start weight management program before quitting, following 
online and dietitian advice 
• Plan to use 10-minute exercise bursts (e.g. rapid walk, arm 
weights, cleaning bath) to cope with nicotine cravings, appetite 
pangs and depressive symptoms17
• Talk to friends about exactly what they can do that is useful
Step 6. provide resources 
provide resources if remains smoke-free
• Keep diary of my extra ‘play money’, how it is to be spent
• Join a dance class
provide resources if relapses 
• Work out what were triggers to relapse. Learn from it rather 
than beating myself up!
• Recontact Quitline
• Remind myself that smoking cessation often takes more than 
one attempt and that often, the subsequent attempts are easier 
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CASE 3: ZOE 
Zoe is a 30-year-old woman who works 
as a casual waitress. She has been smoking 
about 20 roll-your-own cigarettes a day 
since she was 15 years old. She also smokes 
marijuana each evening ‘to relax’ and 
binge drinks alcohol at weekends. She has 
a history of cutting her arms when a teen-
ager. She has overdosed on prescription 
drugs on three occasions, at the ages of 
18 and 20 years, and a few weeks previ-
ously, each time related to a relationship 
break-up. She reports longstanding low 
mood and several episodes of depression 
and has been diagnosed with borderline 
personality disorder. She says that her 
substance use is ‘self-medication – it helps 
me with my moods and my appetite’. She 
says that her psychiatrist has suggested 
she stop substance use, including smoking 
cigarettes, but Zoe says ‘I don’t want to 
put on more weight’. 
Management and outcome 
• The GP asks Zoe about substance 
abuse, eating patterns, self-harming 
and other behaviours related to 
 borderline personality disorder.
• The GP encourages Zoe to use a 
daily chart to plot her mood, sleep, 
alcohol, tobacco and marijuana use 
and cutting behaviour. This enables 
Zoe to note dips in her mood after a 
‘heavy night out’ and triggers for 
smoking, stress and cutting. The GP 
also suggests Zoe list strategies she 
can use at different times of day 
when cigarette cravings occur (see 
Table 2).
• The GP refers Zoe to her psychiatrist 
for assessment of her current status 
and risk issues. 
TABLE 1. pHArmACoLoGICAL AGentS USed In SmokInG CeSSAtIon






• Varying doses for patches (7 to 21 mg, 
16- or 24-hourly) with gum supplementation 
(4 mg unless mild dependence)
• Now PBS listed for use while cutting down 
smoking prior to quitting, to allow 
 stabilisation 
• Nicotine replacement should be considered 
for patients with Fagerstrom score >5 or 
prior failures
Varenicline Nicotine partial 
agonist; binds to 
nicotinic receptors
• Start with 0.5 mg daily for three days, 
increase to 0.5 mg twice daily, then 1 mg 
twice daily
• Treat for 12 weeks; consider further 
12 weeks’ treatment for those who have 
quit successfully
• Nausea is most common adverse effect 
(30% of users)
• Limited evidence of effectiveness and safety 
in people with psychiatric conditions







• Start with 150 mg in morning, after three 
days may increase to 150 mg twice daily
• Start one week prior to quit date, treat for 
seven to 12 weeks, then assess clinical 
need
• Bupropion therapy was added to SSRIs in 
one open study with no problems, but can 
affect doses of some other agents, 
including tricyclic antidepressants
• Specific time-limited indications under 
the PBS
• Has been used effectively with NRT for 
smokers with a history of depression
• Check contraindications (epilepsy, diabetes, 
facial oedema, pregnancy, hypersensitivity 
reactions) 




• Start with 10 to 25 mg, aim for 50 to 100 mg 
at night, as tolerated
• Start at least one week prior to quit date
• Full antidepressant levels usually not 
required for anticraving effect
• Treat for seven to 12 weeks, then assess 
clinical need
• Blood level monitoring possible
• No pronounced hypotensive effects but can 
induce cardiac arrhythmias
• Used effectively for smokers with a history 
of depression, in combination with CBT 
• Cheaper than bupropion
• Avoid if history of arrhythmias; consider 
consulting a cardiologist if in doubt
ABBREVIATIONS: CBT = cognitive behavioural therapy; NRT = nicotine replacement therapy; SSRI = selective serotonin reuptake inhibitor.
SmokerS wItH depreSSIon CONTINUED 
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• The GP arranges for Zoe to see the 
mental health nurse in the practice 
who encourages her to use mind-
fulness techniques; these have 
been shown to be extremely effective 
for emotional regulation and have 
also been used to aid smoking 
cessation.16
• The GP and mental health nurse 
 discuss with Zoe strategies for 
 dealing with impulsivity and when 
and how to engage the mental health 
acute care team. 
• The GP refers Zoe to Quitline and 
enquires about Quitline advice each 
time she visits.
• The GP discusses use of NRT (gum 
and an inhaler) in combination with 
bupropion, an anticraving agent with 
anxiolytic and antidepressant quali-
ties. The GP mentions the need to 
monitor Zoe’s blood pressure while 
she takes these medicines, as com-
bined NRT and bupropion can pro-
duce hypertension in some  people. 
The GP also tells Zoe that these 
medications can be reviewed after 
she completes the course, and could 
be followed by a selective  serotonin 
reuptake inhibitor (SSRI) if needed 
for mood regulation. 
• The GP discusses ways for Zoe to 
improve her general health and 
encourages exercise (e.g. dance, 
swimming).
• In addition, the mental health nurse 
encourages Zoe to look into SMART 
Recovery groups as a way of learning 
cognitive techniques to help with 
cravings and mood regulation 
(see the box on page 48). As an 
 alternative, the mental health nurse 
or a psychologist could discuss 
 cognitive behavioural therapy 
approaches with her: cognitive 
reframing to counter smoking and 
depression, and behavioural activa-
tion to encourage exercise and 
 starting new activities. 
• When Zoe stops smoking, she does 
experience increased depressive 
symptoms and an urge to cut herself. 
However, she is able to talk to the 
acute care team, who visit her in the 
evenings. She also has increased sup-
port from Quitline during this time.
CONCLUSION
GPs are well placed to motivate their 
patients to improve their health-related 
behaviours. People with depression often 
require more intensive individualised 
support to quit smoking that addresses 
mental health issues as well as nicotine 
dependence. A collaborative approach 
should be taken that brings in a range of 
health professionals and services. There 
are some excellent resources available to 
help GPs support their patients with 
depression to quit successfully.  MT
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What are the steps in the 5As 
approach to helping patients quit 
smoking?
TABLE 2. Zoe’S QUIt SmokInG StrAteGIeS
Coping strategies that I can use to help me (list at least one idea in each box)
Strategies during daylight hours Strategies at night-time
Strategies for 
indoors
• Mindfulness exercise each morning and at 
‘punctuation points’ in the day
• Go to the gym
• Plan something to do after work – avoid the pub, 
places where people smoke
• Knitting*
• Stretching exercises




• Walk briskly, take the stairs, have a walk wherever 
possible and especially when stressed
• Go into the garden for some fresh air
• To counter cravings and panicky feelings, do 
some scissor jumps or skipping (until tired)
* Knitting is a suggestion for people to have ‘something to do with their hands’. 
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